216 related articles for article (PubMed ID: 27158739)
1. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
2. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
3. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
4. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
[TBL] [Abstract][Full Text] [Related]
6. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Lambert MP; Shields C; Meadows AT
Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
[TBL] [Abstract][Full Text] [Related]
8. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
11. Outcome of extraocular retinoblastoma in a resource limited center from low middle income country.
Pant G; Verma N; Kumar A; Pooniya V; Gupta SK
Pediatr Hematol Oncol; 2017 Nov; 34(8):419-424. PubMed ID: 29337595
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
15. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
16. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Radhakrishnan V; Sharma S; Vishnubhatla S; Bakhshi S
Br J Ophthalmol; 2013 Jan; 97(1):52-8. PubMed ID: 23117972
[TBL] [Abstract][Full Text] [Related]
17. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
[TBL] [Abstract][Full Text] [Related]
18. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
20. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]